baber/WOPTO huggingface dataset:
Patent AU-2020323901-A1 (AU)
Title: Anti-IL13 antigen binding proteins
Inventor: KIELCZEWSKA AGNIESZKA
IPC: A61P11/00
Filed: 2020-07-24
Abstract: The present invention is related to antibodies directed to IL-13 and uses of such antibodies. For example, in accordance with the present invention, there are provided human monoclonal antibodies directed to IL-13. Isolated polynucleotide sequences encoding, and amino acid sequences comprising, heavy and light chain immunoglobulin molecules, particularly sequences corresponding to contiguous heavy and light chain sequences spanning the framework regions (FR's) and/or complementarity determining regions (CDR's), are provided. Additionally, methods of using these antibodies to treat patients are also provided.
Patent AU-2020358276-A1 (AU)
Title: Active element and method for igniting an active element
Inventor: KADAVANICH VIKORN
IPC: F41J2/02
Filed: 2020-09-01
Abstract: The invention relates to an active element (1), in particular an active decoy element, comprising at least one active mass 10
Patent AU-2020368897-A1 (AU)
Title: Neurostimulation device providing sub-perception stimulation
Inventor: DOAN QUE T
IPC: A61N1/36
Filed: 2020-08-25
Abstract: A method and external device for providing sub-perception stimulation to a patient via an implantable stimulator device is disclosed. Stimulation parameters for the patient are determined that provide sub-perception stimulation to address a symptom of the patient. A schedule is determined to provide scheduled boluses of stimulation, where each bolus comprises a duration during which stimulation is applied to the patient in accordance with the stimulation parameters, and where the scheduled boluses are separated by off times when no stimulation is provided to the patient. Preferably, the duration of each of the scheduled boluses is (3) minutes or longer, and the duration of each of the off times is (30) minutes or greater. Additional boluses can be provided on demand in addition to the scheduled boluses by selecting an option on the external device, although the provision of such additional boluses may be constrained by a lockout period.
Patent AU-2020381501-A1 (AU)
Title: Antenna and glide path array for small footprint aircraft precision approach and landing system
Inventor: FERLA MASSIMILIANO
IPC: H01Q25/00
Filed: 2020-11-13
Abstract: An instrument landing system (ILS) is described. The ILS comprises a plurality of antennas and a plurality of antenna radio units (ARUs). Each ARU of the plurality of ARUs operates to generate a modulated RF signal provided to a different one of the plurality of antennas for transmission. The ILS further comprises a central processing unit that operates to control the ARUs to adjust synchronization between the modulated RF signal provided by the ARUs to the plurality of antennas for transmission.
Patent AU-2020395113-A1 (AU)
Title: Therapeutic editing
Inventor: HUSS DAVID
IPC: A61P25/28
Filed: 2020-12-01
Abstract: Disclosed herein are compositions that comprise engineered polynucleotides, pharmaceutical compositions comprising the same, methods of making the same, and methods of treatment comprising the compositions that comprise the engineered polynucleotides.
Patent AU-2020406726-A1 (AU)
Title: Thienyloxazolones and analogues
Inventor: DUFOUR JEREMY
IPC: A01N43/76
Filed: 2020-12-17
Abstract: The present disclosure relates to substituted thiophene carboxamides derivatives, their use for controlling phytopathogenic microorganisms and compositions comprising thereof.
Patent AU-2020408344-A1 (AU)
Title: Systems and methods for turbinate reduction
Inventor: DOLL SEAN
IPC: A61B18/14
Filed: 2020-12-17
Abstract: An electrosurgical wand for reducing tissue is disclosed. The wand includes a handle and an elongate shaft, the shaft having a major longitudinal axis, a conduit extending 5 therethrough and a non-insulated distal end portion defining a first electrode. The first electrode has a distal most edge configured to mechanically pierce tissue, and an arcuate surface extending proximally from the distal most edge along the major longitudinal axis, the arcuate surface having a convex surface that faces in a distal direction. First and second arcuate edges define lateral edges of the arcuate surface. A second electrode is disposed 10 at an opening of the conduit and electrically isolated from the first electrode. The second electrode comprises an aperture, configured to aspirate fluid and tissue debris therethrough.
Patent AU-2020426356-A1 (AU)
Title: Treating treatment-resistant diabetes with glucokinase activator
Inventor: CHEN LI
IPC: A61K31/4155
Filed: 2020-01-31
Abstract: Provided herein is a method of treating, preventing, or ameliorating one or more symptoms of an untreated or treatment-resistant diabetes with a glucokinase activator, optionally in combination with a dipeptidyl peptidase-4 inhibitor.
Patent AU-2020445257-A1 (AU)
Title: Hypoglycemic event prediction using machine learning
Inventor: ACCIAROLI GIADA
IPC: A61B5/00
Filed: 2020-12-07
Abstract: Hypoglycemic event prediction using machine learning is described. A CGM platform includes a machine learning model trained using historical time series glucose measurements of a user population. Once trained, the machine learning model predicts hypoglycemic events for users. When predicting hypoglycemic events, a time series of glucose measurements for a day time interval is received. The glucose measurements of this time series for the day time interval are provided by a CGM system worn by the user. The machine learning model predicts whether a hypoglycemic event will occur during a night time interval that is subsequent to the day time interval by processing the time series of glucose measurements using the trained machine learning model. The hypoglycemic event prediction is then output, such as via communication and/or display of a notification about the hypoglycemic event prediction.
Patent AU-2020453916-A1 (AU)
Title: Device for biological cell collection and method of use
Inventor: CHAK AMITABH
IPC: A61M25/10
Filed: 2020-06-16
Abstract: A device for collecting a biological sample in a patient, the device including an inflatable portion attached to a tubular member, and designed to expand from within the tubular member when inflated and to retract within the tubular member, a surface on the inflatable portion provided with varied thickness to facilitate movement of the inflatable portion between an expanded state and a retracted state, and a plurality of projections on the surface to allow collection of the biological sample when the inflatable portion is in the expanded state.
Patent WO-2022067379-A1 (WO)
Title: Construction packer
Inventor: MCARTHUR JACOB WAJSMAN
IPC: E04G21/18
Filed: 2021-09-28
Abstract: A construction packer comprising a base part including a base shim and a wall component extending substantially perpendicular to the base shim, the wall component having a first interlocking feature; and a stacking shim configured to be placed on top of the base shim and having a second interlocking feature provided at an edge thereof that engages with the first interlocking feature to provide an assembled construction packer.
Patent AU-2021200083-A1 (AU)
Title: Logical router with multiple routing components
Inventor: ZHANG RONGHUA
IPC: H04L45/60
Filed: 2021-01-07
Abstract: Some embodiments provide a method for implementing a logical router in a network. The method receives a 
definition of a logical router for implementation on a set of network elements. The methods defines several 
routing components for the logical router. Each of the defined routing components includes a separate set of 
routes and separate set of logical interfaces. The method implements the several routing components in the 
network. In some embodiments, the several routing components include one distributed routing component 
and serval centralized routing components.
C-1
3/22
Patent AU-2021201276-A1 (AU)
Title: User interfaces for stored-value accounts
Inventor: VAN OS MARCEL
IPC: G06Q40/04
Filed: 2021-02-26
Abstract: In some examples, an account is provisioned onto an electronic device. In some examples, the 
device receives a value to fund the account provisioned on the electronic device. In some 
examples, the electronic device transacts with a contactless transaction terminal using the 
provisioned account and displays an indication of the transaction. In some examples, the 
electronic device transmits information corresponding to the provisioned account without 
checking for authentication. In some examples, the device receives user input initiating a 
process for moving the account from a first device to a second device. In some examples, the 
device receives account payment credentials from a second device when a set of payment criteria 
are met.
Patent AU-2021201669-A1 (AU)
Title: Methods for treating hypotension
Inventor: CHAWLA LAKHMIR
IPC: A61K38/22
Filed: 2021-03-17
Abstract: The present disclosure relates to the use of angiotensin II in therapeutic methods for the 
treatment of hypotension, especially catecholamine-resistant: hypotension.
Patent AU-2021202136-A1 (AU)
Title: Object tracking system optimization and optimizers
Inventor: DEANGELIS DOUGLAS J
IPC: G06K9/00
Filed: 2021-04-07
Abstract: : 
Systems, methods and software products optimize installation and operation of an object tracking 
system. Performance of the athlete tracking system is continually monitored and optimized based 
upon one or more of: statically positioned tags, grouping tags within two or more tag sets to 
assign ping rates, selecting receiver configuration and aim dynamically based upon 
environmental and situational conditions. Tracking tags are improved to facilitate coupling of 
the tag to an athlete and may be self-configurable. A trackable protection pad allows a tracking 
tag to be positioned substantially horizontal when the athlete is competing. A data replay tool 
replays location tracking information in chronological order and visually plots location of 
tracking tags and errors in the determined location. A tag manager automatically configures the 
tracking tags. A robotic vehicle automated installation of the object tracking system.  
FIG. 1 for publication
1/82 
100 
104(1) 104(2) 104(3) 
102 
- - -101(1) 
E 101(1 101(2) 
101(3) 
ll-101(4) 
Of101(5) 
10 4(4) 104(5) 104(6) 
RECEIVER 
EVENT 110 -T 
8 
PROCESSING HUB 150 
INTERFACE154 
ALGORITHMS152 
APPI/F15CONF 
LOCATE 
DT 7 
DATA 120 
LOCATE 
A MONITOR OPTIMIZER 160 
1 APP130(1) APP130(2) 
_ _ I _ | SOFTWARE 162 
DATA 164 
FIr 1
Patent AU-2021202954-A1 (AU)
Title: Prolactin receptor binding proteins and uses thereof
Inventor: ANDERSON MARK
IPC: A61P35/00
Filed: 2021-05-10
Abstract: PROLACTIN RECEPTOR BINDING PROTEINS AND USES THEREOF 
Abstract 
The present invention encompasses PRLR binding proteins. Specifically, the invention 
relates to antibodies that are chimeric, CDR grafted and humanized antibodies. Preferred 
antibodies have high affinity for hPRLR and neutralize hPRLR activity in vitro and in vivo. An 
antibody of the invention can be a full-length antibody or an antigen-binding portion thereof.  
Methods of making and methods of using the antibodies of the invention are also provided. The 
antibodies, or antibody portions, of the invention are useful for detecting hPRLR and for 
inhibiting hPRLR activity, e.g., in a human subject suffering from a disorder in which hPRLR 
activity is detrimental. Also included in the invention are anti-PRLR antibody drug conjugates 
(ADCs).
Patent AU-2021221736-A1 (AU)
Title: Highly Loaded Metalaxyl-M Formulations
Inventor: HORSFIELD ANDREW
IPC: A01N47/04
Filed: 2021-08-25
Abstract: The invention provides a stable, highly loaded metalaxyl-m soluble liquid 
formulation, having a metalaxyl-m loading of more than 480 g ai/L, a solvent and a 
surfactant.  
14
Patent AU-2021221920-A1 (AU)
Title: Dermal filler compositions
Inventor: NJIKANG GABRIEL N
IPC: A61L27/20
Filed: 2021-08-27
Abstract: DERMAL FILLER COMPOSITIONS 
Abstract 
The present invention provides highly injectable, long-lasting hyaluronic acid
based hydrogel dermal filler compositions made with a di-amine or multiamine 
crosslinker in the presence of a carbodiimide coupling agent.
Patent AU-2021225920-A1 (AU)
Title: Anti-CD137 construct and use thereof
Inventor: XUE JIE
IPC: C07K16/28
Filed: 2021-02-26
Abstract: The present application provides an anti-CD137 construct (for example, anti-CD137 monoclonal antibody and polyspecific antibody) binding to CD137, a nucleic acid molecule encoding an amino acid sequence of the anti-CD137 construct, a vector comprising the nucleic acid molecule, a host cell comprising the vector, a method for preparing the anti-CD137 construct, a pharmaceutical composition comprising the anti-CD137 construct, and a method for using the anti-CD137 construct or composition.
Patent AU-2021240149-A1 (AU)
Title: Connection box for cables
Inventor: PADDICK NATHAN
IPC: H02G15/10
Filed: 2021-09-28
Abstract: Connection box (100) for cables (1) comprising a side wall (10) and an aperture (20) 
on the side wall (10); a sealing element (30) attached to the side wall (10) inside the 
aperture (20) for sealing the aperture (20), the sealing element (30) comprising a first 
5 body (31) sealing a first portion (21) of the aperture (20) and having one or more 
salable openings (40), each opening (40) being configured to receive a portion of a 
cable (1) passing through the aperture (20) of the side wall (10), and a second body 
(32) sealing a second portion (22) of the aperture (20); wherein: the second body (32) 
is movable relative to the first body (31) to seal and unseal the second portion (22) of 
10 the aperture (20) for inserting a cable (1) in the second portion (22) of the aperture 
(20); the first body (31) has a sliding line (50) mutually connecting the openings (40) 
and joining the second portion (22) of the aperture (20) with the openings (40), said 
sliding line (50) allowing a cable (1) passing through the second portion (22) of the 
aperture (20) to slide along the sliding line (50) between the second portion (22) of the 
15 aperture (20) and the openings (50).  
[Fig. 1] 
20
4/6 
200 
100 
10 
30 
lb 
- - - - - - - ---------------------
20 
A..A 
1 
A 
2 
1c 
30 
la 
Fig. 4
Patent AU-2021245248-A1 (AU)
Title: Railroad spike remover
Inventor: BENJAMIN TIMOTHY J
IPC: E01B29/24
Filed: 2021-10-08
Abstract: RAILROAD SPIKE REMOVER 
ABSTRACT 
A portable railroad spike remover comprises a claw assembly extractor that is shaped to engage 
and secure a railroad spike previously installed into a rail tie. The claw assembly extractor may 
include a pair of jaw members that are pivotally connected to each other by a pivoting pin and 
a rotating pin. Each jaw member may include a lower end configured to contact and secure a 
railroad spike and a pair of upper members interlocked with each other and pivotally connected 
to the clevis fastener with the rotating pin. When the drive shaft is rotated, the claw assembly 
extractor and the mounting flange may move inside the main housing in a vertical direction to 
extract the railroad spike from the rail tie.  
18141937_1 (GHMatters) P112817.AU.1
Patent AU-2021253701-A1 (AU)
Title: Three-dimensional bioreactor for viral vector production
Inventor: LING JIAN
IPC: C12M3/00
Filed: 2021-04-09
Abstract: The present disclosure relates to the design, fabrication, and applications of a three-dimensional (3D) bioreactor for expansion of viral vector producing cells and ultimate harvesting of viral vectors. The bioreactor is composed of non-random interconnected voids providing a continuous three-dimensional surface area for cell adherence and growth. The 3D bioreactor is also scalable with a defined geometry, surface coating, and fluidic dynamics to maintain a monolayer cell culture and reduce or prevent cell aggregation, phenotype change, or extracellular production, and is particularly suitable for culturing of HEK 293T cells providing lentiviral vectors under appropriate surface coating of the bioreactor. The invention can also extend to produce other types of viruses and vaccines based on live-attenuated viruses, or inactivated viruses, or viral vectors.
Patent AU-2021254780-A1 (AU)
Title: Compositions and methods to reduce the infectivity of a virus
Inventor: QUAY STEVEN C
IPC: A61K31/231
Filed: 2021-04-15
Abstract: Compositions, devices, and methods for treating a viral infection may comprise use of an enzyme inhibitor, for example a protease inhibitor. A composition of the present disclosure may comprise a dual -action enzyme inhibitor that inhibits two or more enzymes and reduces the infectivity of a virus for a host cell. Additional components may include a bioadhesive that disrupts viral envelopes. A method of treating a viral infection may comprise administering an enzyme inhibitor, such as a dual-action enzyme inhibitor, to a subject and reducing the infectivity of the virus for a host cell of the subject. The compositions may be administered via nasal administration to reduce the infectivity of a viral infection, for example a coronavirus infection.
Patent AU-2021266193-A1 (AU)
Title: Non-pertubative measurements of low and null magnetic field in high temperature plasmas
Inventor: GUPTA DEEPAK K
IPC: G21B1/05
Filed: 2021-11-08
Abstract: OF THE DISCLOSURE 
Systems and methods that facilitate non-pertubative measurements of low and null 
magnetic field in high temperature plasmas.
Patent AU-2021266344-A1 (AU)
Title: Adeno-associated for therapeutic delivery to central nervous system
Inventor: MCIVOR R SCOTT
IPC: C12N7/00
Filed: 2021-11-12
Abstract: A method to prevent, inhibit or treat one or more symptoms associated with disease of the 
central nervous system by intranasally, intrathecally, intracerebrovascularly or intravenously 
administering a rAAV encoding a gene product associated with the disease, e.g., a mammal in which 
the gene product is absent or present at a reduced level relative to a mammal without the disease, in 
an amount effective, e.g., to provide for cross-correction.
Patent AU-2021281670-A1 (AU)
Title: Hydrolysate based biostimulant compositions derived from methanotroph, methods, and applications thereof
Inventor: KUMAR SARMA RAJEEV
IPC: C05F5/00
Filed: 2021-05-28
Abstract: The present disclosure relates to protein hydrolysate based biostimulant composition derived from methanotrophic bacteria, and methods for enhancing agricultural productivity. In particular, the compositions disclosed herein comprise a protein-derived component in an amount of about 30% or less with respect to weight of the composition, wherein said protein-derived component is obtained from a methanotrophic bacterium. The present biostimulant composition finds applications in methods for improving plant performance along with methods for reducing the need of external chemical fertilizer-based inputs for plant growth.
Patent AU-2021322827-A1 (AU)
Title: An access control system for an excavator
Inventor: MILLER DUNCAN
IPC: E06C5/06
Filed: 2021-07-23
Abstract: An access control system for an excavator access system has a ladder control lever connected to a hydraulic system of the access system. The lever has an up position which raises the ladder, a down position which lowers the ladder and a neutral position. The lever returns itself to the neutral position. The control system has a latching control circuit comprising a ladder valve contact switch operably coupled to the ladder control lever; a ladder position sensor which detects if the retractable ladder is in the raised position and a latching valve relay controlling a latching valve which controls the hydraulic cylinder. The control system controls the hydraulic cylinder to keep the retractable ladder in the raised position when the ladder valve contact switch indicates that the ladder control lever is in the neutral position and the ladder position sensor detects that the retractable ladder is in the raised position.
Patent AU-2021363134-A1 (AU)
Title: Compositions comprising fabaceae family plant components, processes of preparation and uses thereof
Inventor: LAVALLÉE PIERRE
IPC: C12N9/00
Filed: 2021-10-21
Abstract: The present disclosure relates to processes for recovering valuable products from
Patent AU-2021366372-A1 (AU)
Title: Prostheses
Inventor: MATHIAS ROD
IPC: A61F2/36
Filed: 2021-10-15
Abstract: A set of ceramic acetabular cup prostheses (100) and ceramic femoral head prostheses (200) suitable for use therewith wherein the bearing diameter centre point of the cup is laterally offset from the outer diameter centre point of the cup along the longitudinal axis of the cup and wherein, for each cup in the set starting from the smallest cup in the set, the outer diameter increases in 2 mm increments and the inner diameter increases in less than 2 mm increments.
Patent AU-2021374038-A1 (AU)
Title: System for stimulation of biological tissue
Inventor: SOEKADAR SURJO RAPHAEL
IPC: A61N2/12
Filed: 2021-11-08
Abstract: The invention relates to a system for magnetic stimulation of biological tissue, comprising at least two magnetic field generating devices (D1-D4) for generating time-varying magnetic fields, wherein the magnetic field generating devices (D1-D4) are to be arranged relative to the tissue in such a way that their time-varying magnetic fields at least partially overlap in the tissue; and at least one controlling arrangement (50) for controlling the two magnetic field generating devices (D1-D4). According to the invention, the controlling arrangement (50) is configured to control at least one (D2, D4) of the two magnetic field generating devices (D1-D4) in such a way that the time-varying magnetic field generated by the at least one device (D2, D4) is phase modulated.
Patent AU-2021381350-A1 (AU)
Title: Antagonists of the muscarinic acetylcholine receptor m4
Inventor: BENDER AARON
IPC: A61P25/16
Filed: 2021-11-18
Abstract: Disclosed herein are 6-((octahydrocyclopenta[c]pyrrol-5-yl)amino)pyridazin-3-yl- substituted pyridinones, pyrimidinones, and pyridazinones, useful as antagonists of the muscarinic acetylcholine receptor M
Patent AU-2021404116-A1 (AU)
Title: Oral treatment device
Inventor: TAO LILI
IPC: A46B15/00
Filed: 2021-10-25
Abstract: An oral treatment device is provided. The oral treatment device comprises image sensor equipment configured to generate image data indicative of a sequence of images representing at least a portion of an oral cavity of a user. The oral treatment device comprises a controlled configured to process the image data to determine a movement parameter indicative of movement of the oral treatment device relative to an interproximal gap between adjacent teeth in the oral cavity of the user. The controller is configured to control the oral treatment device to perform an action based on the determined movement parameter.
Patent AU-2021429970-A1 (AU)
Title: Geometrically deformable implantable containment devices for retention of biological moieties
Inventor: CULLY EDWARD
IPC: A61K9/00
Filed: 2021-02-25
Abstract: Described herein are encapsulation devices that include an inner layer, an outer layer, a cell containment layer positioned between the inner and outer layer, and structural elements disposed within the cell containment layer to separate the inner and outer layers by a separation distance. The structural elements define reservoir spaces for the retention of a biological moiety (such as cells) therein. The structural elements maintain a separation distance both under external compressive forces and under internal expansive forces, such as undergoing a geometric change in the encapsulation device or during crushing and subsequent expansion of the cell encapsulation device. In some embodiments, a reinforcing layer is positioned between the inner layer and the cell containment layer. In addition, the encapsulation device may include at least one configuration element. Methods of placing encapsulation devices in a body conduit intra-luminally, extra-luminally, and via an open surgical procedure are also disclosed.